Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

19 projects found matching your search criteria :

  1. The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

    Call: SONATA 9 , Panel: NZ4

    Principal investigator: dr Ewelina Rojewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  2. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

  3. Exploring kinase hyperactivation as an innovative approach for chemo-immunotherapy for B cell acute lymphoblastic leukem...

    Call: PRELUDIUM BIS 5 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Firczuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  4. The EU system of regulatory exclusivities and rewards - towards a better-balanced legal framework of access to healthcar...

    Call: OPUS 25 , Panel: HS5

    Principal investigator: dr Żaneta Zemła-Pacud

    Instytut Nauk Prawnych Polskiej Akademii Nauk

  5. unESKAPEable. Innovative antibiotics leads based on bifunctionalsed metallacarboranes to combat ESKAPE pathogens.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Jakub Cebula

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  6. Normalization of energy metabolism as a way to develop innovative antithrombotic therapies

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Patrycja Kaczara

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  7. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Marcin Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

  8. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Anna Pogorzelska

    Narodowy Instytut Leków

  9. An innovative method of treating acute liver failure using amniotic stem cells isolated from the human placenta.

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Patrycja Wieczorek

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  10. Pulse electroporation as an innovative method in the process of the so-called 'root milking", use in the adaptation of m...

    Call: SONATA 16 , Panel: NZ9

    Principal investigator: dr Sylwester Ślusarczyk

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

  11. Towards innovative strategy for treatment of Alzheimer's Disease via dual inhibition of receptor 5-HT6 and kinase CDK5.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Sylwia Sudoł

    Uniwersytet Jagielloński, Collegium Medicum

  12. Ethics of research with human subjects in precision medicine

    Call: PRELUDIUM 18 , Panel: HS1

    Principal investigator: Karolina Strzebońska

    Uniwersytet Jagielloński, Collegium Medicum

  13. Thymol-derived 1,3,5-triazines, the non-indole and non-sulfone 5-HT6 receptor ligands, as a starter in search for an inn...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  14. New Hexokinase II inhibitors, in search of innovative therapeutic approaches to cancer treatment

    Call: PRELUDIUM 14 , Panel: NZ7

    Principal investigator: Mateusz Tomczyk

    Politechnika Śląska, Wydział Chemiczny

  15. Mitochondria transfer as an innovative method of restoring stemness of adipose-derived stem cells isolated from horses s...

    Call: PRELUDIUM 14 , Panel: NZ7

    Principal investigator: dr Katarzyna Kornicka-Garbowska

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

  16. New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Michał Załuski

    Uniwersytet Jagielloński, Collegium Medicum, Wydział Farmaceutyczny

  17. Innovative delivery systems of active pharmaceutical ingredients whose effectiveness needs frequent dosage algorithms

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr Joanna Gościańska

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  18. INNOvative antiSEPTic agents for a therapy with a broad spectrum of action

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr Sebastian Kraszewski

    Politechnika Wrocławska

  19. New, innovative hybrid materials useful in regenerative medicine based soley on natural components

    Call: OPUS 10 , Panel: ST8

    Principal investigator: dr hab. Beata Kolesińska

    Politechnika Łódzka, Wydział Chemiczny